{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:05:45Z","timestamp":1774497945893,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1532\/ijh97.a10416","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T18:11:58Z","timestamp":1123524718000},"page":"35-37","source":"Crossref","is-referenced-by-count":2,"title":["Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita: Report of a Case"],"prefix":"10.1007","volume":"82","author":[{"given":"Patrizia","family":"Comoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Cheng","family":"Huanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","first-page":"11","author":"Dokal, I","year":"1999","unstructured":"Dokal I. Dyskeratosis congenita. Br J Haematol. 1999;105(suppl 1): 11-15.","journal-title":"Br J Haematol"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1046\/j.1365-2141.1998.01103.x","author":"Knight, S","year":"1998","unstructured":"Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I. Dyskeratosis congenita (DC) registry: identification of new features of DC. Br J Haematol. 1998;103:990-996.","journal-title":"Br J Haematol"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","author":"Dokal, I","year":"2000","unstructured":"Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768-779.","journal-title":"Br J Haematol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1996.424984.x","author":"Langston, AA","year":"1996","unstructured":"Langston AA, Sanders JE, Deeg HJ, et al. Allogeneic marrow transplantation for aplastic anemia associated with dyskeratosis congenita. Br J Haematol. 1996;92:758-765.","journal-title":"Br J Haematol"},{"key":"E00005","first-page":"1931","year":"2000","unstructured":"Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO\/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood. 2000;95:1931-1934.","journal-title":"Blood"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.1988.tb04188.x","author":"Kawano, Y","year":"1988","unstructured":"Kawano Y, Nissen C, Gratwohl A, Speck B. Immunostimulatory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effect. Br J Haematol. 1988;68:115-119.","journal-title":"Br J Haematol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348","author":"Bacigalupo, A","year":"1995","unstructured":"Bacigalupo A, Broccia G, Corda G, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood. 1995;85:1348-1353.","journal-title":"Blood"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/jmg.35.12.993","volume":"35","author":"Knight, SW","year":"1998","unstructured":"Knight SW, Vulliamy TJ, Heiss NS, et al. 1.4Mb candidate gene region for X-linked dyskeratosis congenita defined by combined haplotype and X-chromosome inactivation analysis. J Med Genet. 1998;35:993-996.","journal-title":"J Med Genet."},{"key":"E00009","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-4362.2002.01373_3.x","author":"Yilmaz, K","year":"2002","unstructured":"Yilmaz K, Inaloz HS, Unal B, Guler E. Dyskeratosis congenita with isolated neutropenia and granulocyte colony-stimulating factor treatment. Int J Dermatol. 2002;41:170-172.","journal-title":"Int J Dermatol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1700674","author":"Yabe, M","year":"1997","unstructured":"Yabe M, Yabe H, Hattori K, et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19: 389-392.","journal-title":"Bone Marrow Transplant"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","author":"Rocha, V","year":"1998","unstructured":"Rocha V, Devergie A, Socie G, et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol. 1998;103:243-248.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.A10416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T19:16:23Z","timestamp":1586373383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.A10416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7,1]]}},"alternative-id":["3PJC3CTK293MVQGD"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.a10416","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7,1]]}}}